Age-Related Discrimination in the Use of Fibrinolytic Therapy in Acute Myocardial Infarction in Norway
Pettersen, Kjell I.
Age and Ageing. 1995 May; 24(3): 198-203.
Age-related use of fibrinolytic therapy in acute myocardial infarction was studied for patients admitted to the intensive care unit in four hospitals comprising 10% of the national hospital bed capacity in Norway. Altogether, 446 patients were included. All had validated acute myocardial infarction or acute ischaemic coronary heart disease treated with fibrinolytic medication. The fibrinolytic treatment rate decreased linearly from 74% among patients younger than 50 years to 15% among those older than 80 (p less than 0.0001). In a multiple logistic regression, low age, short pre-hospital time and no previous myocardial infarction strongly predicted use of fibrinolytic therapy (p less than 0.0001), and male sex was a significant predictor for use of fibrinolytic therapy (p = 0.01).
Showing items related by title, author, creator and subject.
Age-Related Differences in in-Hospital Mortality and the Use of Thrombolytic Therapy for Acute Myocardial Infarction Boucher, Jean-Marc; Racine, Normand; Thanh, Thao Huynh; Rahme, Elham; Brophy, James; LeLorier, Jacques; Theroux, Pierre (Quebec Acute Coronary Care Working Group, 2001-05-01)
Informed Consent in Emergency Research: Prehospital Thrombolytic Therapy for Acute Myocardial Infarction Grim, Paula S.; Singer, Peter A.; Gramelspacher, Gregory P.; Feldman, Ted; Childers, Rory W.; Siegler, Mark (1989-07-14)The problem of informed consent to research in emergency care is examined, using as an example a pilot trial of prehospital administration of thrombolytic therapy for acute myocardial infarction. Current federal regulations ...